ORAMED PHARMACEUTICALS INC. Stock Issued During Period, Shares, Reverse Stock Splits
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ORAMED PHARMACEUTICALS INC. stock issued during period, shares, reverse stock splits for fiscal 2022 was 1.82M shares.
- ORAMED PHARMACEUTICALS INC. stock issued during period, shares, reverse stock splits for fiscal 2021 was 1.82M shares.
| Period end | Stock Issued During Period, Shares, Reverse Stock Splits 3 month | Stock Issued During Period, Shares, Reverse Stock Splits 12 month |
|---|---|---|
| 2022-12-31 | 1.82M shares 10-K · filed 2023-03-06 | |
| 2021-08-31 | 1.82M shares 10-K · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |